Last Posted: Dec-23-2016 2PM
Liquid Biopsy expanded expanded
Last Posted: Dec 22, 2016
- Circulating Tumor DNA May Serve as a Prognostic Marker in Pancreatic Cancer
J Cavallo, ASCO Post, December 20, 2016 - Circulating tumor DNA technology: the future of cancer management?
L Blackburn, PHG Foundation, December 20, 2016 - Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study
CA Parkinson et al, PLOS Medicine, December 20, 2016 - KRAS mutations in the circulating free DNA (cfDNA) of non-small cell lung cancer (NSCLC) patients.
Garzón Mónica et al. Translational lung cancer research 2016 Oct 5(5) 511-516 - Technological considerations for genome-guided diagnosis and management of cancer.
Lennon Niall J et al. Genome medicine 2016 Oct 8(1) 112 - The cancer bloodhounds
Nature Biotechnology, November 2016 - Clinical Utility of Circulating Tumor DNA for Molecular Assessment and Precision Medicine in Pancreatic Cancer.
Takai Erina et al. Advances in experimental medicine and biology 2016 92413-17 - The Role of Genomic Profiling in Advanced Breast Cancer: The Two Faces of Janus.
Eralp Yesim et al. Translational oncogenomics 2016 8(Suppl 1) 1-7 - ESR1 Mutations in Cell-Free DNA of Breast Cancer Predictive “Tip of the Iceberg"
Suzanne A. W. Fuqua et al, JAMA Oncology, August 11, 2016 - Prevalence of ESR1 Mutations in Cell-Free DNA and Outcomes in Metastatic Breast Cancer A Secondary Analysis of the BOLERO-2 Clinical Trial
Sarat Chandarlapaty, et al, JAMA Oncology, August 11, 2016 - The Holy Grail of Liquid Biopsies
Genome Magazine, June 23, 2016 - Blood Test for Genetic Changes in Tumors Shows Promise as Alternative to Tumor Biopsy
NCI, June 14, 2016 - ‘Liquid biopsy’ study offers hope for a blood test to find cancer
L McGinley, Washington Post, June 4, 2016 - ASCO 2016: Liquid Biopsy May Help Guide Treatment Decisions for Patients With Advanced Solid Tumors
ASCO Post, June 4, 2016 - AR-V7 Protein in Circulating Tumor Cells—The Decider for Therapy
RB Montgomery et al, JAMA Oncology, June 4, 2016 - The Quest for a Simple Cancer Test
J Perkle, NOvaNExt, PBS, May 19, 2016
Most Recent Scientific Publications from Weekly Horizon Scans
From Genomics & Health Impact Scan Database
This database includes published scientific literature on evidence-based translation of genomic discoveries into improved health care and disease prevention that have a potential impact on population health.
- KRAS mutations in the circulating free DNA (cfDNA) of non-small cell lung cancer (NSCLC) patients.
Garzón Mónica et al. Translational lung cancer research 2016 Oct 5(5) 511-516 - Technological considerations for genome-guided diagnosis and management of cancer.
Lennon Niall J et al. Genome medicine 2016 Oct 8(1) 112 - Clinical Utility of Circulating Tumor DNA for Molecular Assessment and Precision Medicine in Pancreatic Cancer.
Takai Erina et al. Advances in experimental medicine and biology 2016 92413-17 - The Role of Genomic Profiling in Advanced Breast Cancer: The Two Faces of Janus.
Eralp Yesim et al. Translational oncogenomics 2016 8(Suppl 1) 1-7 - Blood Test for Genetic Changes in Tumors Shows Promise as Alternative to Tumor Biopsy
NCI, June 14, 2016
From HuGE Literature Finder Database
This database contains published literature on genetic associations and other human genome epidemiology
- Detection of the T790M mutation of EGFR in plasma of advanced non-small cell lung cancer patients with acquired resistance to tyrosine kinase inhibitors (West Japan oncology group 8014LTR study).
Oncotarget 2016 Aug .
Takahama Takayuki, Sakai Kazuko, Takeda Masayuki, Azuma Koichi, Hida Toyoaki, Hirabayashi Masataka, Oguri Tetsuya, Tanaka Hiroshi, Ebi Noriyuki, Sawa Toshiyuki, Bessho Akihiro, Tachihara Motoko, Akamatsu Hiroaki, Bandoh Shuji, Himeji Daisuke, Ohira Tatsuo, Shimokawa Mototsugu, Nakanishi Yoichi, Nakagawa Kazuhiko, Nishio Kazu - Evaluation of a novel saliva-based epidermal growth factor receptor mutation detection for lung cancer: A pilot study.
Thoracic cancer 2016 Jul 7 (4): 428-36.
Pu Dan, Liang Hao, Wei Fang, Akin David, Feng Ziding, Yan QingXiang, Li Yin, Zhen Yan, Xu Lin, Dong Gaochao, Wan Huajing, Dong Jingsi, Qiu Xiaoming, Qin Changlong, Zhu Daxing, Wang Xi, Sun Tong, Zhang Wenbiao, Li Canjun, Tang Xiaojun, Qiao Youlin, Wong David T W, Zhou Qingh - K-Ras mutation detection in liquid biopsy and tumor tissue as prognostic biomarker in patients with pancreatic cancer: a systematic review with meta-analysis.
Medical oncology (Northwood, London, England) 2016 Jul 33 (7): 61.
Li Tao, Zheng Yuanting, Sun Hong, Zhuang Rongyuan, Liu Jing, Liu Tianshu, Cai Weim - Limits and potential of targeted sequencing analysis of liquid biopsy in patients with lung and colon carcinoma.
Oncotarget 2016 Jul .
Rachiglio Anna Maria, Abate Riziero Esposito, Sacco Alessandra, Pasquale Raffaella, Fenizia Francesca, Lambiase Matilde, Morabito Alessandro, Montanino Agnese, Rocco Gaetano, Romano Carmen, Nappi Anna, Iaffaioli R Vincenzo, Tatangelo Fabiana, Botti Gerardo, Ciardiello Fortunato, Maiello Monica R, De Luca Antonella, Normanno Nico - Detection of TP53/PIK3CA Mutations in Cell-Free Plasma DNA From Metastatic Breast Cancer Patients Using Next Generation Sequencing.
Clinical breast cancer 2016 May .
Nakauchi Chiaki, Kagara Naofumi, Shimazu Kenzo, Shimomura Atsushi, Naoi Yasuto, Shimoda Masafumi, Kim Seung Jin, Noguchi Shinzabu
.png)
No hay comentarios:
Publicar un comentario